State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. [PDF]
J Nucl Cardiol, 2019 Singh V +5 more
europepmc +4 more sources
Radionuclide imaging of apoptosis for clinical application. [PDF]
Eur J Nucl Med Mol Imaging, 2022 Apoptosis was a natural, non-inflammatory, energy-dependent form of programmed cell death (PCD) that can be discovered in a variety of physiological and pathological processes.
Qin X, Jiang H, Liu Y, Zhang H, Tian M.
europepmc +2 more sources
Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine. [PDF]
Eur J Nucl Med Mol Imaging, 2022 Targeted radionuclide theranostics is becoming more and more prominent in clinical oncology. Currently, most nuclear medicine compounds researched for cancer theranostics are directed towards targets expressed in only a small subset of cancer types ...
van der Heide CD, Dalm SU.
europepmc +2 more sources
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy. [PDF]
Eur J Nucl Med Mol Imaging, 2022 Fibroblast activation protein (FAP) is a membrane-bound protease that has limited expression in normal adult tissues but is highly expressed in the tumor microenvironment of many solid cancers.
Zboralski D +21 more
europepmc +2 more sources
Quantitative imaging for targeted radionuclide therapy dosimetry : technical review [PDF]
Theranostics, 2017 Targeted radionuclide therapy (TRT) is a promising technique for cancer therapy. However, in order to deliver the required dose to the tumor, minimize potential toxicity in normal organs, as well as monitor therapeutic effects, it is important to assess ...
Ao, Edwin CI +5 more
core +3 more sources
Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools
Biomedicines, 2016 For treatment of systemic malignancies, when external radiation therapy is not applicable, radionuclide therapy can be an alternative. In this form of therapy, radionuclides are administered to the patient, often in a form where the radionuclide is ...
Michael Ljungberg +1 more
doaj +2 more sources
Prospective of68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation [PDF]
Contrast Media & Molecular Imaging, 2018 During the last decade, the utilization of 68Ga for the development of imaging agents has increased considerably with the leading position in the oncology. The imaging of infection and inflammation is lagging despite strong unmet medical needs.
Irina Velikyan
openalex +2 more sources
Radionuclide Imaging in Ischemic Stroke [PDF]
Journal of Nuclear Medicine, 2014 Ischemic stroke is caused by interruption or significant impairment of blood supply to the brain, which leads to a cascade of metabolic and molecular alterations resulting in functional disturbance and morphologic damage. The changes in regional cerebral blood flow and regional metabolism can be assessed by radionuclide imaging, especially SPECT and ...
W. Heiss
openaire +3 more sources
Radionuclide Imaging of Atherothrombotic Diseases. [PDF]
Curr Cardiovasc Imaging Rep, 2019 Purpose of ReviewA variety of approaches and molecular targets have emerged in recent years for radionuclide-based imaging of atherosclerosis and vulnerable plaque using single photon emission computed tomography (SPECT) and positron emission tomography (
Stacy MR.
europepmc +2 more sources
The next era of renal radionuclide imaging: novel PET radiotracers. [PDF]
Eur J Nucl Med Mol Imaging, 2019 Although single-photon-emitting radiotracers have long been the standard for renal functional molecular imaging, recent years have seen the development of positron emission tomography (PET) agents for this application.
Werner RA +7 more
europepmc +2 more sources